BriaCell Announces Update on Previously Announced Securities Buyback Program and Participation at Upcoming Conferences Biotech Investing
LUMYKRAS® Receives Positive Opinion From EMA CHMP For Patients With KRAS G12C-Mutated Advanced Non-Small Cell Lung Cancer Market News
SHAREHOLDER ALERT: CLAIMSFILER REMINDS BMY, EAR, HYZN INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits Pharmaceutical Investing
Everest Medicines and Gilead Sciences Jointly Announce Phase 2b Study of Sacituzumab Govitecan Conducted in China of Patients With Metastatic Triple-Negative Breast Cancer Meets Primary Overall Response Rate Endpoint Pharmaceutical Investing
BELLUS Health Reports Third Quarter 2021 Financial Results and Business Highlights Pharmaceutical Investing
Aurinia Pharmaceuticals to Present at the 2021 Jefferies London Healthcare Conference Pharmaceutical Investing
Sirona Biochem Announces 2021 Annual Meeting Results: Shareholders Approve All Resolutions With Majority Vote Biotech Investing
Lexaria 2022 R&D Programs to Include Investigations into Alzheimer's Disease and Diabetes Cannabis Investing News
AbbVie, University of Chicago Extend Research Collaboration to Support Preclinical Oncology Research Through 2025 Pharmaceutical Investing
